Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes

Background. This analysis examined the efficacy of fidaxomicin versus vancomycin in 406 Canadian patients with Clostridium difficile infection (CDI), based on data from 2 randomized, clinical trials. Methods. Patients received fidaxomicin or vancomycin 1. Patients were assessed for clinical response...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Can J Infect Dis Med Microbiol
Autors principals: Lee, Christine, Louie, Thomas J., Weiss, Karl, Valiquette, Louis, Gerson, Marvin, Arnott, Wendy, Gorbach, Sherwood L.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2016
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4904592/
https://ncbi.nlm.nih.gov/pubmed/27366179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/8048757
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars